Off‐label use of drugs in pregnancy: A critical review of guidelines, current practices, and a clinical perspective
International Journal of Gynecology & Obstetrics · 2025
DOI: 10.1002/ijgo.70076 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Vitalba Gallitelli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gynecology and Obstetrics, Hospital Isola Tiberina Gemelli Isola, Rome, Italy. Hauptthemen laut MEDLINE: Off-Label Use. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 96 Literaturangaben.
Abstract (Originalsprache)
Objective
The objective of this narrative review was twofold: to delineate the usage patterns of the main off‐label drugs during pregnancy (i.e., misoprostol, nifedipine, and corticosteroids) and to offer a medical examiner's perspective on the use of these medications.
Methods
An extensive review of the literature was performed to assess the off‐label use of corticosteroids, nifedipine, and misoprostol in pregnancy.
Results
Overall, 503 records about the use of off‐label medicines during pregnancy were identified. After the exclusion of papers published in languages other than English and experimental studies in animals, 340 studies were considered eligible. Studies with medicines other than corticosteroids, misoprostol, and nifedipine were removed, leaving a total of 240 articles. From the remaining records, 24 reports were not retrieved. The research strategy allowed the final identification of 76 references.
Conclusion
Off‐label drug use in obstetrics has transitioned from being an exception to a routine, scientifically validated practice. While its application is justified by clinical outcomes and international protocols, healthcare providers must navigate a strict framework of ethical and legal responsibility.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Gynecology and Obstetrics, Hospital Isola Tiberina Gemelli Isola, Rome, Italy.
- Division of Gynecology and Obstetrics, IRCSS Azienda Ospedaliera_Universitaria of Bologna, Bologna, Italy.
- Dipartimento di Scienze Anatomiche, Istologiche, Medico Legali e dell'apparato Locomotore, Sapienza Università di Roma, Rome, Italy.
- Department Maternal and Child Health, Obstetrics and Gynecology Unit, Hospital AO for Emergency Cannizzaro, Catania, Italy.
- Azienda USL Toscana Centro, Gynecology and Obstetrics Department, Santa Maria Annunziata Hospital, Florence, Italy.
- Pediatric Gynecology Unit, Meyer Children's Hospital IRCCS, Florence, Italy.
ORCID-Profile: Georgios Eleftheriou
Zitieren
APA
Gallitelli, V., Franco, R., Guidi, S., Zaami, S., Parasiliti, M., Vidiri, A., Perelli, F., Plotti, F., Eleftheriou, G., Mattei, A., Scambia, G., & Cavaliere, A. F. (2025). Off‐label use of drugs in pregnancy: A critical review of guidelines, current practices, and a clinical perspective. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70076
Vancouver
Gallitelli V, Franco R, Guidi S, Zaami S, Parasiliti M, Vidiri A, et al. Off‐label use of drugs in pregnancy: A critical review of guidelines, current practices, and a clinical perspective. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70076
BibTeX
@article{Gallitelli2025,
author = {Gallitelli, Vitalba and Franco, Rita and Guidi, Sofia and Zaami, Simona and Parasiliti, Marco and Vidiri, Annalisa and Perelli, Federica and Plotti, Francesco and Eleftheriou, Georgios and Mattei, Alberto and Scambia, Giovanni and Cavaliere, Anna Franca},
title = {Off‐label use of drugs in pregnancy: A critical review of guidelines, current practices, and a clinical perspective},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
doi = {10.1002/ijgo.70076}
}
EUVIMED